View Author
patient 25bright t cells transplantation cd 25bright cells level study expression t-cell function il -2 number blood transplant kidney effect analysis treatment cp -690 550 -690 serum proliferation foxp 3 control sample allograft response capacity p-stat immunol 25neg esrf patients result 25+ rapamycin p-stat 5 levels dialysis recipient tacrolimu suppressive presence depletion lymphocyte kidney transplant patients rejection figure baseline increase production month inhibition bd biosciences inhibitor day 1 table donor cd 4ϩcd t-cells day 29 fraction suppressive function cd 25neg cells il -2 production population change kidney transplant recipients subset cohort monotherapy stimulation organ pathway rotterdam group count 30 mg bid proliferative response erasmus university rotterdam tolerance disease cd 4ϩcd cells
7 Most Recent Publications
|
Monitoring of the immunomodulatory effect of CP-690,550 by analysis of the JAK/STAT pathway in kidney transplant patients
(Article)
Quaedackers, M.E. Mol, W.M. Korevaar, S.S. Gurp, E. van IJcken, W.F.J. van Chan, G. Weimar, W. Baan, C.C. |
2009-10-01
|
|
Monotherapy rapamycin allows an increase of CD4+ CD25 bright+ FoxP3+ T cells in renal recipients
(Article)
Hendrikx, T.K. Velthuis, J.H.L. Klepper, M. Gurp, E. van Geel, A. Schoordijk, W. Baan, C.C. Weimar, W. |
2009-09-01
|
|
End-stage renal failure and regulatory activities of CD4 +CD25bright+FoxP3+ T-cells
(Article)
Hendrikx, T.K. Gurp, E. van Mol, W.M. Schoordijk, W. Sewgobind, V.D.K.D. IJzermans, J.N.M. Weimar, W. Baan, C.C. |
2009-06-01
|
|
Generation of donor-specific regulatory t-cell function in kidney transplant patients
(Article)
Hendrikx, T.K. Gurp, E. van Baan, C.C. Sewgobind, V.D.K.D. Mol, W.M. Schoordijk, W. Klepper, M. Velthuis, J.H.L. Geel, A. IJzermans, J.N.M. Weimar, W. |
2009-02-15
|
|
The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients
(Article)
Gurp, E. van Schoordijk-Verschoor, W. Klepper, M. Korevaar, S.S. Chan, G. Weimar, W. Baan, C.C. |
2009-01-15
|
|
Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: Preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics
(Article)
Gurp, E. van Weimar, W. Krishnaswami, S. Chow, V. Chan, G. Gaston, R. Brennan, D. Mendez, R. Pirsch, J. Swan, S. Pescovitz, M.D. Ni, G. Wang, C. |
2008-08-01
|
|
Functional CD25bright+ alloresponsive T cells in fully immunosuppressed renal allograft recipients
(Article)
Baan, C.C. Velthuis, J.H.L. Gurp, E. van Mol, W.M. Klepper, M. IJzermans, J.N.M. Weimar, W. |
2007-01-01
|